Dr. E’s 85-year-old patient José came to his last endo appointment with a stellar CGM report. Jose’s download stated that his time in range was 78%, his average glucose was 146 mg/dL, and his estimated A1c was 6.8% without any low blood sugars. But a very important data point was missing from the CGM report’s overview, providing an important reminder for both patients and providers.
read more →
When diabetes lives with you day-to-day like a stage five clinger, it can be easy to feel like advancements in care aren’t happening at a fast enough pace. But we’re here to tell you, things are happening! Here’s a short list of some of the progress we saw in 2024, including new pumps, new CGMs, and exciting research studies with promising results.
read more →
If you have type 2 diabetes, it’s time to get PUMPED! Insulin pumps are becoming more available for people with T2D, and it’s about time. Never worn a pump before? No problem…Drs. E+P explain how they work, key features, basal and bolus options, current pumps on the market, and a new pump designed for the type 2 community that’s coming soon.
read more →
History has been just been made! The first-ever year-long CGM sensor was recently approved by the FDA. The Eversense 365 is an implantable CGM that’s cleared for use in people 18 years and older with type 1 or type 2 diabetes. It offers several unique benefits including on-body vibration alerts and a removable transmitter.
read more →
The Dexcom Stelo CGM was FDA-approved in March for adults with type 2 diabetes who are not on insulin, and it’s now available for purchase without a prescription. Stelo sends continuous blood sugar readings to a smartphone 24/7, revealing how food, exercise, and sleep can affect your blood glucose. It’s an empowering tool to help people with T2D better understand how glucose affects their health.
read more →
